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Background: The prevalence of obesity, and morbid obesity in particular continues to rise rapidly in the United States. Morbidly obese patients 
are at increased risk for cardiac disease and are more likely to need invasive cardiac procedures. There is a paucity of data on the prevalence and 
implications of morbid obesity among patients undergoing PCI.
Methods: We examined the prevalence of morbid obesity (BMI ≥40 kg/m2) among 227,044 patients undergoing PCI and enrolled in the BMC2 
registry from 1998-2009.
Results: There has been a steady increase in the proportion of morbidly obese patients undergoing PCI from 1998 to 2009 (Figure). Compared 
with overweight patients (BMI 25-30 kg/m2), these patients had significant increases in vascular complications (2.82% vs. 2.25%, p<0.05) and 
contrast induced nephropathy (CIN) (4.74% vs. 3.01%, p<0.05) but there was no difference in mortality (0.90% vs. 1.06%, p=0.14).
Conclusions: The percentage of morbidly obese patients presenting for PCI has increased by 191% over the study period. Morbidly obese patients 
are at higher risk for vascular complications and CIN. The dramatic increase in the number of morbidly obese patients has important implications for 
technical considerations of cardiac catheterization, design of the catheterization lab to accommodate these patients and more importantly for the 
prevention of obesity.
